The involvement of the adrenergic system in feeding and eating disorders. A systematic review

References

• American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders. 5th ed. Washington (DC): American Psychiatric Association. 10.1176/appi.books.9780890425596
   Google Scholar
• Appolinario JC, Bacaltchuk J, Sichieri R, Claudino AM, Godoy-Matos A, Morgan C, Zanella MT, Coutinho W. 2003. A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder. Arch Gen Psychiatry. 60(11):1109–1116. doi: 10.1001/archpsyc.60.11.1109.
   PubMed Web of Science ®Google Scholar
• Appolinario JC, Godoy-Matos A, Fontenelle LF, Carraro L, Cabral M, Vieira A, Coutinho W. 2002. An open-label trial of sibutramine in obese patients with binge-eating disorder. J Clin Psychiatry. 63(1):28–30. doi: 10.4088/jcp.v63n0106.
   PubMed Web of Science ®Google Scholar
• Bandelow B, Allgulander C, Baldwin DS, Costa DLdC, Denys D, Dilbaz N, Domschke K, Eriksson E, Fineberg NA, Hättenschwiler J, et al. 2023. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive–compulsive and posttraumatic stress disorders – version 3. Part I: anxiety disorders. World J Biol Psychiatry. 24(2):79–117. doi: 10.1080/15622975.2022.2086295.
   PubMed Web of Science ®Google Scholar
• Bandelow B, Baldwin D, Abelli M, Bolea-Alamanac B, Bourin M, Chamberlain SR, Cinosi E, Davies S, Domschke K, Fineberg N, et al. 2017. Biological markers for anxiety disorders, OCD and PTSD: a consensus statement. Part II: neurochemistry, neurophysiology and neurocognition. World J Biol Psychiatry. 18(3):162–214. doi: 10.1080/15622975.2016.1190867.
   PubMed Web of Science ®Google Scholar
• Bello NT, Walters AL, Verpeut JL, Caverly J. 2014. Dietary-induced binge eating increases prefrontal cortex neural activation to restraint stress and increases binge food consumption following chronic guanfacine. Pharmacol Biochem Behav. 125:21–28. doi: 10.1016/j.pbb.2014.08.003.
   PubMed Web of Science ®Google Scholar
• Bello NT, Yeh C-Y, James MH. 2019. Reduced sensory-evoked locus coeruleus-norepinephrine neural activity in female rats with a history of dietary-induced binge eating. Front Psychol. 10:1966. doi: 10.3389/fpsyg.2019.01966.
   PubMed Web of Science ®Google Scholar
• Bernardi S, Pallanti S. 2010. Successful duloxetine treatment of a binge eating disorder: a case report. J Psychopharmacol. 24(8):1269–1272. doi: 10.1177/0269881108098822.
   PubMed Web of Science ®Google Scholar
• Brambilla F, Lampertico M, Sali L, Cavagnini F, Invitti C, Maggioni M, Candolfi C, Panerai AE, Müller EE. 1987. Clonidine stimulation in anorexia nervosa: growth hormone, cortisol, and beta-endorphin responses. Psychiatry Res. 20(1):19–31. doi: 10.1016/0165-1781(87)90120-x.
   PubMed Web of Science ®Google Scholar
• Calandra C, Russo RG, Luca M. 2012. Bupropion versus sertraline in the treatment of depressive patients with binge eating disorder: retrospective cohort study. Psychiatr Q. 83(2):177–185. doi: 10.1007/s11126-011-9192-0.
   PubMed Web of Science ®Google Scholar
• Carbone EA, Caroleo M, Rania M, Calabrò G, Staltari FA, de Filippis R, Aloi M, Condoleo F, Arturi F, Segura-Garcia C, et al. 2021. An open-label trial on the efficacy and tolerability of naltrexone/bupropion SR for treating altered eating behaviours and weight loss in binge eating disorder. Eat Weight Disord. 26(3):779–788. doi: 10.1007/s40519-020-00910-x.
   PubMed Web of Science ®Google Scholar
• Casper RC, Schlemmer RF, Javaid JI. 1987. A placebo-controlled crossover study of oral clonidine in acute anorexia nervosa. Psychiatry Res. 20(3):249–260. doi: 10.1016/0165-1781(87)90085-0.
   PubMed Web of Science ®Google Scholar
• Cederlöf M, Thornton LM, Baker J, Lichtenstein P, Larsson H, Rück C, Bulik CM, Mataix-Cols D. 2015. Etiological overlap between obsessive–compulsive disorder and anorexia nervosa: a longitudinal cohort, multigenerational family and twin study. World Psychiatry. 14(3):333–338. doi: 10.1002/wps.20251.
   PubMed Web of Science ®Google Scholar
• Chandler DJ, Waterhouse BD, Gao WJ. 2014. New perspectives on catecholaminergic regulation of executive circuits: evidence for independent modulation of prefrontal functions by midbrain dopaminergic and noradrenergic neurons. Front Neural Circuits. 8:53. doi: 10.3389/fncir.2014.00053.
   PubMed Web of Science ®Google Scholar
• Christensen RC, Averbuch RN. 2009. The use of duloxetine in chronic bulimia nervosa: a case report. Psychiatry. 6:27–28.
   PubMedGoogle Scholar
• Cools R. 2016. The costs and benefits of brain dopamine for cognitive control. Wiley Interdiscip Rev Cogn Sci. 7(5):317–329. doi: 10.1002/wcs.1401.
   PubMed Web of Science ®Google Scholar
• Dagan Y, Yager J. 2018. Severe bupropion XR abuse in a patient with long‐standing bulimia nervosa and complex PTSD. Int J Eat Disord. 51(10):1207–1209. doi: 10.1002/eat.22948.
   PubMed Web of Science ®Google Scholar
• Devoto P, Flore G. 2006. On the origin of cortical dopamine: is it a co-transmitter in noradrenergic neurons? Curr Neuropharmacol. 4(2):115–125. doi: 10.2174/157015906776359559.
   PubMed Web of Science ®Google Scholar
• Eisenhofer G, Kopin IJ, Goldstein DS. 2004. Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev. 56(3):331–349. doi: 10.1124/pr.56.3.1.
   PubMed Web of Science ®Google Scholar
• El-Giamal N, de Zwaan M, Bailer U, Lennkh C, Schüssler P, Strnad A, Kasper S. 2000. Reboxetine in the treatment of bulimia nervosa: a report of seven cases. Int Clin Psychopharmacol. 15(6):351–356. doi: 10.1097/00004850-200015060-00006.
   PubMed Web of Science ®Google Scholar
• Eli K, Warin M. 2018. Anthropological perspectives on eating disorders: deciphering cultural logics. Transcult Psychiatry. 55(4):443–453. doi: 10.1177/1363461518784385.
   PubMed Web of Science ®Google Scholar
• Fassino S, Daga GA, Boggio S, Garzaro L, Pierò A. 2004. Use of reboxetine in bulimia nervosa: a pilot study. J Psychopharmacol. 18(3):423–428. doi: 10.1177/026988110401800314.
   PubMed Web of Science ®Google Scholar
• Ferreira GM, Nazar BP, Da Silva MR, Carriello MA, Freitas S, Appolinario JC. 2018. Misuse of sibutramine and bulimia nervosa: a dangerous combination. Braz J Psychiatry. 40(3):343. doi: 10.1590/1516-4446-2018-0004.
   PubMedGoogle Scholar
• Ghanemi A, Hu X. 2015. Elements toward novel therapeutic targeting of the adrenergic system. Neuropeptides. 49:25–35. doi: 10.1016/j.npep.2014.11.003.
   PubMed Web of Science ®Google Scholar
• Grilo CM, Lydecker JA, Fineberg SK, Moreno JO, Ivezaj V, Gueorguieva R. 2022. Naltrexone-bupropion and behavior therapy, alone and combined, for binge-eating disorder: randomized double-blind placebo-controlled trial. Am J Psychiatry. 179(12):927–937. doi: 10.1176/appi.ajp.20220267.
   PubMedGoogle Scholar
• Grilo CM, Lydecker JA, Morgan PT, Gueorguieva R. 2021. Naltrexone + bupropion combination for the treatment of binge-eating disorder with obesity: a randomized, controlled pilot study. Clin Ther. 43(1):112–122.e1. doi: 10.1016/j.clinthera.2020.10.010.
   PubMed Web of Science ®Google Scholar
• Guerdjikova AI, McElroy SL, Winstanley EL, Nelson EB, Mori N, McCoy J, Keck PE, Hudson JI. 2012. Duloxetine in the treatment of binge eating disorder with depressive disorders: a placebo-controlled trial. Int J Eat Disord. 45(2):281–289. doi: 10.1002/eat.20946.
   PubMed Web of Science ®Google Scholar
• Guerdjikova AI, Walsh B, Shan K, Halseth AE, Dunayevich E, McElroy SL. 2017. Concurrent improvement in both binge eating and depressive symptoms with naltrexone/bupropion therapy in overweight or obese subjects with major depressive disorder in an open-label, uncontrolled study. Adv Ther. 34(10):2307–2315. doi: 10.1007/s12325-017-0613-9.
   PubMed Web of Science ®Google Scholar
• Hay P. 2020. Current approach to eating disorders: a clinical update. Intern Med J. 50(1):24–29. doi: 10.1111/imj.14691.
   PubMed Web of Science ®Google Scholar
• Hazen E, Fava M. 2006. Successful treatment with duloxetine in a case of treatment refractory bulimia nervosa: a case report. J Psychopharmacol. 20(5):723–724. doi: 10.1177/0269881106060502.
   PubMed Web of Science ®Google Scholar
• Himmerich H, Lewis YD, Conti C, Mutwalli H, Karwautz A, Sjögren JM, Uribe Isaza MM, Tyszkiewicz-Nwafor M, Aigner M, McElroy SL, et al. 2023. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines update 2023 on the pharmacological treatment of eating disorders. World J Biol Psychiatry. 1–64. doi: 10.1080/15622975.2023.2179663.
   PubMed Web of Science ®Google Scholar
• Holly EN, Miczek KA. 2016. Ventral tegmental area dopamine revisited: effects of acute and repeated stress. Psychopharmacology. 233(2):163–186.
   PubMed Web of Science ®Google Scholar
• Jenkins ZM, Eikelis N, Phillipou A, Castle DJ, Wilding HE, Lambert EA. 2021. Autonomic nervous system function in anorexia nervosa: a systematic review. Front Neurosci. 15:682208. doi: 10.3389/fnins.2021.682208.
   PubMed Web of Science ®Google Scholar
• Jung Y-H, Jang JH, Lee D, Choi Y, Choi S-H, Kang D-H. 2019. Relationships between catecholamine levels and stress or intelligence. Neurochem Res. 44(5):1192–1200. doi: 10.1007/s11064-019-02762-z.
   PubMed Web of Science ®Google Scholar
• Kontis D, Theochari E. 2012. Dopamine in anorexia nervosa: a systematic review. Behav Pharmacol. 23(5–6):496–515. doi: 10.1097/FBP.0b013e328357e115.
   PubMed Web of Science ®Google Scholar
• Koo-Loeb JH, Pedersen C, Girdler SS. 1998. Blunted cardiovascular and catecholamine stress reactivity in women with bulimia nervosa. Psychiatry Res. 80(1):13–27. doi: 10.1016/s0165-1781(98)00057-2.
   PubMed Web of Science ®Google Scholar
• Krieger K, Klimke A, Henning U. 2004. Antipsychotic drugs influence transport of the β-adrenergic antagonist [3H]-dihydroalprenolol into neuronal and blood cells. World J Biol Psychiatry. 5(2):100–106. doi: 10.1080/15622970410029918.
   PubMed Web of Science ®Google Scholar
• Lechin F, Dijs B, Pardey-Maldonado B, Baez S, Lechin EM. 2011. Anorexia nervosa versus hyperinsulinism: therapeutic effects of neuropharmacological manipulation. Ther Clin Risk Manag. 7:53–58. doi: 10.2147/TCRM.S16958.
   PubMed Web of Science ®Google Scholar
• Lechin F, Dijs B, Pardey-Maldonado B, Rivera JE, Baez S, Lechin ME. 2010. Anorexia nervosa depends on adrenal sympathetic hyperactivity: opposite neuroautonomic profile of hyperinsulinism syndrome. Diabetes Metab Syndr Obes. 3:311–317. doi: 10.2147/DMSO.S10744.
   PubMedGoogle Scholar
• Leombruni P, Lavagnino L, Gastaldi F, Vasile A, Fassino S. 2009. Duloxetine in obese binge eater outpatients: preliminary results from a 12-week open trial. Hum Psychopharmacol. 24(6):483–488. doi: 10.1002/hup.1040.
   PubMed Web of Science ®Google Scholar
• Lora-Vilchis MC, Chambert G, Rodriguez-Zendejas AM, Soto-Mora LM, Russek M, Epstein AN. 1988. Ontogeny of alpha- and beta-adrenergic anorexia in rats. Am J Physiol. 255(6 Pt 2):R908–R913. doi: 10.1152/ajpregu.1988.255.6.R908.
   PubMedGoogle Scholar
• Lores Arnaiz GR, Antonelli MC. 2016. In search of concomitant alterations of dopaminergic and neurotensinergic systems in stress conditions. Neurochem Res. 41:423–430.
   PubMed Web of Science ®Google Scholar
• Luck P, Mikhailidis DP, Dashwood MR, Barradas MA, Sever PS, Dandona P, Wakeling A. 1983. Platelet hyperaggregability and increased alpha-adrenoceptor density in anorexia nervosa. J Clin Endocrinol Metab. 57(5):911–914. doi: 10.1210/jcem-57-5-911.
   PubMed Web of Science ®Google Scholar
• Mayhew AJ, Pigeyre M, Couturier J, Meyre D. 2018. An evolutionary genetic perspective of eating disorders. Neuroendocrinology. 106(3):292–306. doi: 10.1159/000484525.
   PubMed Web of Science ®Google Scholar
• Mezey E, Eisenhofer G, Harta G, Hansson S, Gould L, Hunyady B, Hoffman BJ. 1996. A novel nonneuronal cate-cholaminergic system: exocrine pancreas synthesizes and releases dopamine. Proc Natl Acad Sci USA. 93(19):10377–10382. doi: 10.1073/pnas.93.19.10377.
   PubMed Web of Science ®Google Scholar
• Milano W, Petrella C, Casella A, Capasso A, Carrino S, Milano L. 2005. Use of sibutramine an inhibitor of the reuptake of serotonin and noradrenaline, in the treatment of binge eating disorder: a placebo-controlled study. Adv Ther. 22(1):25–31. doi: 10.1007/BF02850181.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG, Group TPRISMA. 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 6(7):e1000097. doi: 10.1371/journal.pmed.1000097.
   PubMed Web of Science ®Google Scholar
• Nakagawa K, Akikawa K, Namioka M, Kubo M, Matsubara M. 1985. Responses to epinephrine in patients with anorexia nervosa. Endocrinol Jpn. 32(6):845–849. doi: 10.1507/endocrj1954.32.845.
   PubMedGoogle Scholar
• Nasse JS, Travers JB. 2014. Adrenoreceptor modulation of oromotor pathways in the rat medulla. J Neurophysiol. 112(3):580–593. doi: 10.1152/jn.00091.2014.
   PubMed Web of Science ®Google Scholar
• Nicoll RA, Malenka RC, Kauer JA. 1990. Functional comparison of neurotransmitter receptor subtypes in mammalian central nervous system. Physiol Rev. 70(2):513–565. doi: 10.1152/physrev.1990.70.2.513.
   PubMed Web of Science ®Google Scholar
• Otake K, Ruggiero DA, Nakamura Y. 1995. Adrenergic innervation of forebrain neurons that project to the paraventricular thalamic nucleus in the rat. Brain Res. 697(1–2):17–26. doi: 10.1016/0006-8993(95)00749-g.
   PubMed Web of Science ®Google Scholar
• Pieribone VA, Aston-Jones G. 1991. Adrenergic innervation of the rat nucleus locus coeruleus arises predominantly from the C1 adrenergic cell group in the rostral medulla. Neuroscience. 41(2–3):525–542. doi: 10.1016/0306-4522(91)90346-p.
   PubMed Web of Science ®Google Scholar
• Pruccoli J, Bergonzini L, La Tempa A, Parmeggiani A. 2022. Antipsychotics in the treatment of children and adolescents with anorexia nervosa: a systematic review. Biomedicines. 10(12):3167. doi: 10.3390/biomedicines10123167.
   PubMed Web of Science ®Google Scholar
• Pruccoli J, Parmeggiani A, Cordelli D, Lanari M. 2021. The role of the noradrenergic system in eating disorders: a systematic review. Int J Mol Sci. 22(20):11086. doi: 10.3390/ijms222011086.
   PubMed Web of Science ®Google Scholar
• Rivero G, Martín-Guerrero I, de Prado E, Gabilondo AM, Callado LF, García-Sevilla JA, García-Orad Á, Meana JJ. 2016. Alpha2C-adrenoceptor Del322-325 polymorphism and risk of psychiatric disorders: significant association with opiate abuse and dependence. World J Biol Psychiatry. 17(4):308–315. doi: 10.3109/15622975.2016.1142608.
   PubMed Web of Science ®Google Scholar
• Robertson S, Plummer NW, Marchena J, Jensen P. 2013. Developmental origins of central norepinephrine neuron diversity. Nat Neurosci. 16(8):1016–1023. doi: 10.1038/nn.3458.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Zendejas AM, Chambert G, Lora-Vilchis MC, Epstein AN, Russek M. 1986. Ontogeny of epinephrine-induced anorexia in rats. Am J Physiol. 250(2 Pt 2):R313–R317. doi: 10.1152/ajpregu.1986.250.2.R313.
   PubMedGoogle Scholar
• Russek M, Vega C, Barrera J, Soto-Mora LM, Lanzagorta A, Racotta R. 1987. Anorexia elicited by different catecholamines in rats. Appetite. 9(2):119–126. doi: 10.1016/0195-6663(87)90041-9.
   PubMed Web of Science ®Google Scholar
• Schulz C, Eisenhofer G, Lehnert H. 2003. Principles of catecholamine biosynthesis, metabolism and release. Front Horm Res. 31:1–25.
   Web of Science ®Google Scholar
• Sekaninova N, Bona Olexova L, Visnovcova Z, Ondrejka I, Tonhajzerova I. 2020. Role of neuroendocrine, immune, and au-tonomic nervous system in anorexia nervosa-linked cardiovascular diseases. Int J Mol Sci. 21(19):7302. doi: 10.3390/ijms21197302.
   PubMed Web of Science ®Google Scholar
• Silveira RO, Zanatto V, Appolinário JC, Kapczinski F. 2005. An open trial of reboxetine in obese patients with binge eating disorder. Eat Weight Disord. 10(4):e93–e96. doi: 10.1007/BF03327498.
   PubMedGoogle Scholar
• Smythies SJ. 2005. The adrenaline system. Int Rev Neurobiol. 64:213–215.
   PubMed Web of Science ®Google Scholar
• Stefănescu AM, Popa M, Dumitriu L. 1988. Free 3-methoxy-4-hydroxyphenylglycol (MHPG) in human urine: metabolic routes, biochemical and clinical significance in healthy and obese children. Endocrinologie. 27(1):41.
   Google Scholar
• Tyszkiewicz-Nwafor M, Slopien A, Dmitrzak-Węglarz M, Rybakowski F. 2019. Adiponectin and resistin in acutely ill and weight-recovered adolescent anorexia nervosa: association with psychiatric symptoms. World J Biol Psychiatry. 20(9):723–731. doi: 10.1080/15622975.2018.1492735.
   PubMed Web of Science ®Google Scholar
• Van Loon GR. 1980. Abnormal catecholamine mechanisms in hypothalamic-pituitary disorders. Metabolism. 29(11 Suppl 1):1198–1202. doi: 10.1016/0026-0495(80)90030-x.
   PubMed Web of Science ®Google Scholar
• Waterhouse BD, Navarra RL. 2019. The locus coeruleus-norepinephrine system and sensory signal processing: a historical review and current perspectives. Brain Res. 1709:1–15. doi: 10.1016/j.brainres.2018.08.032.
   PubMed Web of Science ®Google Scholar
• Weissman RS. 2019. The role of sociocultural factors in the etiology of eating disorders. Psychiatr Clin North Am. 42(1):121–144. doi: 10.1016/j.psc.2018.10.009.
   PubMed Web of Science ®Google Scholar
• Wellman PJ. 2000. Norepinephrine and the control of food intake. Nutrition. 16(10):837–842. doi: 10.1016/s0899-9007(00)00415-9.
   PubMed Web of Science ®Google Scholar
• Wilfley DE, Crow SJ, Hudson JI, Mitchell JE, Berkowitz RI, Blakesley V, Walsh BT, Sibutramine Binge Eating Disorder Research Group. 2008. Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind study. Am J Psychiatry. 165(1):51–58. doi: 10.1176/appi.ajp.2007.06121970.
   PubMed Web of Science ®Google Scholar
• Willeit M, Praschak-Rieder H, Neumeister K. 2001. Reboxetine in a patient with seasonal bulimia resistant to SSRIs and light therapy. Int J Psychiatry Clin Pract. 5:207–209.
   PubMed Web of Science ®Google Scholar
• Wright BE, Svec F, Porter J. 1995. Central effects of dehydroepiandrosterone in Zucker rats. Int J Obes Relat Metab Disord. 19(12):887–892.
   PubMed Web of Science ®Google Scholar
• Zipfel S, Giel KE, Bulik CM, Hay P, Schmidt U. 2015. Anorexia nervosa: aetiology, assessment, and treatment. Lancet Psychiatry. 2(12):1099–1111. doi: 10.1016/S2215-0366(15)00356-9.
   PubMed Web of Science ®Google Scholar